| Index | — | P/E | 75.68 | EPS (ttm) | 0.37 | Insider Own | 1.79% | Shs Outstand | 37.87M | Perf Week | 1.49% |
| Market Cap | 1.06B | Forward P/E | 35.22 | EPS next Y | 0.80 | Insider Trans | -0.07% | Shs Float | 23.06M | Perf Month | -3.31% |
| Enterprise Value | 900.39M | PEG | 0.91 | EPS next Q | — | Short Float | 3.80% | Perf Quarter | -8.82% | ||
| Income | 14.00M | P/S | 1.31 | EPS this Y | — | Short Ratio | 6.03 | Perf Half Y | 1.08% | ||
| Sales | 812.00M | P/B | 1.83 | EPS next Y | 62.24% | ROA | 1.87% | Short Interest | 877.34K | Perf YTD | 2.60% |
| Book/sh | 15.29 | P/C | 4.89 | EPS next 5Y | 82.95% | ROE | 2.44% | 52W High | 33.55 -16.54% | Perf Year | -4.27% |
| Cash/sh | 5.73 | P/FCF | 11.28 | EPS past 3/5Y | — | ROIC | 0.78% | 52W Low | 24.43 14.61% | Perf 3Y | 2.87% |
| Dividend Est. | 0.50 (1.79%) | EV/EBITDA | 25.01 | Sales past 3/5Y | -16.61% 1.04% | Gross Margin | 35.63% | Volatility | 2.24% 2.38% | Perf 5Y | -39.35% |
| Dividend TTM | 0.50 (1.79%) | EV/Sales | 1.11 | EPS Y/Y TTM | — | Oper. Margin | 1.26% | ATR (14) | 0.74 | Perf 10Y | 14.29% |
| Dividend Ex-Date | Sep 15, 2026 | Quick Ratio | 15.46 | Sales Y/Y TTM | 11.85% | Profit Margin | 1.77% | RSI (14) | 44.76 | Recom | 3.00 |
| Dividend Gr. 3/5Y | -30.66% — | Current Ratio | 15.46 | EPS Q/Q | 135.71% | SMA20 | 0.03% | Beta | 1.25 | Target Price | 26.00 |
| Payout | 80.26% | Debt/Eq | 0.10 | Sales Q/Q | 18.02% | SMA50 | -5.77% | Rel Volume | 0.93 | Prev Close | 27.92 |
| Employees | 854 | LT Debt/Eq | 0.10 | Earnings | Nov 06 | SMA200 | -2.60% | Avg Volume | 154.60K | Price | 28.00 |
| IPO Date | Oct 31, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 233.33% 4.43% | Net Debt/EBITDA | -4.44 | Volume | 143,996 | Change | 0.29% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-23-22 | Reiterated | Wells Fargo | Underweight | $26 |
| Apr-09-20 | Downgrade | Wells Fargo | Equal Weight → Underweight | |
| Aug-22-18 | Downgrade | JMP Securities | Market Outperform → Market Perform | |
| Jan-24-18 | Upgrade | JMP Securities | Market Perform → Market Outperform | |
| Nov-14-17 | Upgrade | Citigroup | Neutral → Buy | |
| Nov-10-15 | Upgrade | Goldman Sachs | Sell → Neutral | |
| Oct-26-15 | Downgrade | JMP Securities | Outperform → Market Perform | |
| Aug-12-15 | Downgrade | Goldman Sachs | Neutral → Sell |
Marcus & Millichap, Inc. (MMI) is a prominent investment brokerage firm specializing in commercial real estate. Operating across the United States and Canada, the company furnishes comprehensive investment brokerage and financing solutions for both buyers and sellers in the commercial property market. Their core service portfolio spans commercial real estate sales, financial arrangements, in-depth market research, and strategic advisory. These services cater to a diverse array of commercial asset classes, including multifamily dwellings, retail spaces, office buildings, industrial properties, single-tenant net leased assets, seniors' housing, self-storage facilities, hospitality venues, medical offices, and manufactured housing communities. Beyond direct brokerage, MMI functions as a crucial financial intermediary, providing sophisticated capital markets solutions for commercial real estate. This includes structuring various debt types (senior and mezzanine), facilitating joint ventures, arranging preferred equity, executing loan sales, and offering specialized consultative and due diligence expertise to property owners, developers, investors, and capital sources. Furthermore, the company offers a range of supplementary services, encompassing detailed research, advisory, and consulting. These are provided to a broad client base, including developers, lenders, property owners, Real Estate Investment Trusts (REITs), high-net-worth individuals, pension fund advisors, and other institutional entities. Marcus & Millichap, Inc. was established in 1971 and maintains its corporate headquarters in Calabasas, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 812 | 755 | 696 | 646 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 522 | 495 | 431 | 407 | — | — | — | — | — | |
| Gross Profit | 289 | 260 | 265 | 239 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 72 | 0 | 281 | 285 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 207 | 273 | 16 | 14 | — | — | — | — | — | |
| Operating Income | 10 | -12 | -33 | -59 | — | — | — | — | — | |
| Interest Expense | 0 | 1 | 1 | 1 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 15 | 16 | 21 | 20 | — | — | — | — | — | |
| Net Income Before Taxes | 24 | 3 | -13 | -40 | — | — | — | — | — | |
| Income Taxes | 10 | 5 | -1 | -6 | — | — | — | — | — | |
| Consolidated Net Income | 14 | -2 | -12 | -34 | — | — | — | — | — | |
| Net Income From Continuing Operations | 14 | -2 | -12 | -34 | — | — | — | — | — | |
| Net Income | 14 | -2 | -12 | -34 | — | — | — | — | — | |
| EPS (Recurring) | 0.37 | -0.05 | -0.32 | -0.88 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.37 | -0.05 | -0.32 | -0.88 | — | — | — | — | — | |
| EPS (Diluted) | 0.37 | -0.05 | -0.32 | -0.88 | — | — | — | — | — | |
| EBITDA | 36 | 16 | 4 | -26 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 75.68 | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.31 | 1.41 | 2.14 | 2.64 | — | — | — | — | — | |
| Gross Margin | 35.59 | 34.44 | 38.07 | 37.00 | — | — | — | — | — | |
| Operating Margin | 1.23 | -1.59 | -4.74 | -9.13 | — | — | — | — | — | |
| Net Margin | 1.72 | -0.26 | -1.72 | -5.26 | — | — | — | — | — | |
| Shares Outstanding | 38 | 39 | 39 | 39 | — | — | — | — | — | |
| Market Capitalization | 1,064 | 1,064 | 1,492 | 1,704 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Nadji Hessam | Chief Executive Officer | Sep 10 '26 | Option Exercise | 0.00 | 30,000 | 0 | 329,982 | Sep 15 |
| DeGennaro Steven F. | EVP and CFO | Aug 10 '26 | Option Exercise | 0.00 | 1,500 | 0 | 42,590 | Aug 12 |
| Parker John David | EVP & COO | Aug 10 '26 | Option Exercise | 0.00 | 2,808 | 0 | 44,270 | Aug 12 |
| Nadji Hessam | Chief Executive Officer | Jun 11 '26 | Sale | 30.39 | 500 | 15,193 | 480 | Jun 12 |
| Parker John David | EVP & COO | May 08 '26 | Option Exercise | 0.00 | 2,000 | 0 | 42,483 | May 12 |
| MARTIN LAURALEE | Director | Aug 11 '25 | Buy | 29.34 | 3,422 | 100,397 | 17,748 | May 04 |
| Nadji Hessam | Chief Executive Officer | Mar 13 '26 | Sale | 25.60 | 1,300 | 33,280 | 480 | Mar 16 |
| De Bosschere Fabrice | Chief Accounting Officer | Mar 10 '26 | Option Exercise | 0.00 | 2,087 | 0 | 2,734 | Mar 12 |
| DeGennaro Steven F. | EVP and CFO | Mar 10 '26 | Option Exercise | 0.00 | 16,140 | 0 | 42,775 | Mar 12 |
| LaBerge Gregory A. | SVP & Chief Client Officer | Mar 10 '26 | Option Exercise | 0.00 | 9,697 | 0 | 7,297 | Mar 12 |
| Nadji Hessam | Chief Executive Officer | Mar 10 '26 | Option Exercise | 0.00 | 81,115 | 0 | 321,753 | Mar 12 |
| Parker John David | EVP & COO | Mar 10 '26 | Option Exercise | 0.00 | 24,201 | 0 | 43,701 | Mar 12 |
| Nadji Hessam | Chief Executive Officer | Sep 10 '25 | Option Exercise | 0.00 | 30,000 | 0 | 290,703 | Sep 12 |
| DeGennaro Steven F. | EVP and CFO | Aug 10 '25 | Option Exercise | 0.00 | 1,500 | 0 | 1,500 | Aug 12 |
| DeGennaro Steven F. | EVP and CFO | Aug 08 '25 | Option Exercise | 0.00 | 3,000 | 0 | 30,989 | Aug 12 |